LO
Cannara Biotech Inc.
LOVFF · OTC
$1.50 +3.74% (+$0.05)
1M +4.75%
Market Cap $208.4M
P/E Ratio 19.20x
Div. Yield -
ROE 10.22%
Bulios Fair Price
$1.76
17.3% upside
Trenutna cena
$1.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LOVFF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
68 /100
Cheap P/E 19.20x
EV/EBITDA 8.71x
P/S 1.77x
Growth
100 /100
Growing EPS growth 74.83%
Rev. growth 44.13%
Book val. growth 15.27%
Profitability
60 /100
Moderate Gross margin 42.80%
Net margin 9.22%
Op. margin 15.95%
Quality
57 /100
Average ROIC 10.03%
ROE 10.22%
ROA 7.68%
Debt
95 /100
Low Debt/Equity 0.30x
Current ratio 2.99x
Int. coverage 7.71x
Stability
44 /100
Moderate Beta 0.39x
Rev. volatility 14.33%
EPS volatility 103.34%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LOVFF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Zohar Krivorot
Employees
452
Headquarters
Saint-Laurent
Prihajajoči dogodki
23 NOV.
Earnings
Upcoming earnings report
24 NOV.
Earnings
Upcoming earnings report